The article explores the impact of antidepressants and other non-antibiotic drugs on the development of resistance in bacteria.
In the interview, Lisa Maier talks about the conclusions that can be drawn from her latest study results.
Lisa Maier completed her studies in biochemistry at the University of Tübingen (2004-2009) and her PhD in the laboratory of Wolf-Dietrich Hardt at ETH Zurich (2014). As part of the interdisciplinary postdoctoral program at EMBL in Heidelberg, she worked in the groups of Nassos Typas and Kiran Patil (2015-2018). In 2019, she returned to Tübingen as CMFI and Emmy Noether junior research group leader. In April 2022, she has been appointed to the professorship ‘Microbiome-Host Interactions’ at the Faculty of Medicine/University of Tübingen.
Her lab uses automated high-throughput and multi-readout approaches to systematically study the lifestyle of bacteria in the human microbiome. The resulting datasets are then used as a starting point for mechanistic studies to uncover the molecular details of how the microbiome interacts with its host.